• Ocular Therapeutix to present at the OIS Retina Innovation Summit in Montréal on July 14, 2026.
• Phase 3 SOL-1 results for OTX-TKI in wet age-related macular degeneration to be presented at the ASRS annual meeting, July 15-18, 2026.
• Management to join the HC Wainwright Ophthalmology Virtual Conference for a fireside chat on July 22, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607010700PRIMZONEFULLFEED9754943) on July 01, 2026, and is solely responsible for the information contained therein.